Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dental PCLBKK:D +0.66%89 EV-to-EBIT is 9.70 as of Aug. 17, 2026, which is 59% below its 10-year median of 23.87. GuruFocus rates BKK:D with a GF Score™ of 89/100 and a GF Value™ of ฿3.66 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 473 Healthcare Providers & Services companies, Dental PCL ranks better than 74.84% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Dental PCL's Enterprise Value for the quarter that ended in Mar. 2026 was ฿1,170 Mil.
Dental PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿132 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dental PCL EV-to-EBIT Related Terms
Dental PCL EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Dental PCL's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Dental PCL's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dental PCL EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dental PCL's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Dental PCL's EV-to-EBIT falls into.
Dental PCL's current Enterprise Value is ฿1,280 Mil.
Dental PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿132 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dental PCL (BKK:D) has a EV-to-EBIT of 9.70 as of Aug. 17, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Dental PCL and its competitors. This is 59% below median its historical median of 23.87. According to the industry distribution chart, Dental PCL ranks #119 out of 473 companies in the Healthcare Providers & Services industry, placing it in the top 25.2%.
Is Dental PCL's EV-to-EBIT too high?
Dental PCL's current EV-to-EBIT of 9.70 is 59% below median its 10-year median of 23.87. The Healthcare Providers & Services industry median EV-to-EBIT is 15.81. Dental PCL's value of 9.70 is 38.6% below this industry median. Based on the distribution chart, Dental PCL ranks #119 out of 473 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Dental PCL has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dental PCL's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dental PCL ranks #119 out of 473 companies for EV-to-EBIT. This puts Dental PCL in the upper half of its industry. The industry median EV-to-EBIT is 15.81. Dental PCL's value of 9.70 is 38.6% below this benchmark. While the company's 10-year median is 23.87 vs. the industry median of 15.81, Dental PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.81, based on 473 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dental PCL's current EV-to-EBIT of 9.70 is 38.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Dental PCL and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dental PCL's current EV-to-EBIT is 9.70, which is 59% below median its own 10-year median of 23.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dental PCL stock overvalued right now?
Based on GuruFocus' analysis, Dental PCL (BKK:D) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿3.66, compared to a current price of ฿3.06 — trading 16.4% below its estimated fair value. The current EV-to-EBIT is 9.70, which is 59% below median its 10-year median of 23.87 and 38.6% below the Healthcare Providers & Services industry median of 15.81. Dental PCL's overall GF Score™ is 89/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Dental PCL (BKK:D), the current EV-to-EBIT is 9.70 as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dental PCL (BKK:D) Overvalued in 2026?
Based on GuruFocus' analysis, Dental PCL stock appears to be undervalued.
The current stock price of ฿3.06 is trading 16.4% below its estimated GF Value™ of ฿3.66.
GuruFocus considers Dental PCL to be Modestly Undervalued.
Key valuation signals for BKK:D:
EV-to-EBIT: 9.70 (59% below median its 10-year median of 23.87)
GF Value™: ฿3.66 vs. price of ฿3.06 (16.4% below fair value)
Industry Position: 38.6% below the Healthcare Providers & Services median (#119 of 473)
No single metric tells the full story. See the BKK:D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dental Corp PCL provides dental service, dental laboratory service, and distributes dental supplies and equipment. The group's operations involve two reportable business segments: Dental service and Distribution of dental supplies and equipment. The majority of its revenue is derived from the Dental service segment, which offers various dental treatments and services such as dental diagnosis, root canal treatments, cosmetic surgery, treatment of gum diseases, orthodontic dentistry services, etc. The group is managed and operates principally in Thailand.
89GF Score
Get the complete analysis for BKK:D
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:D has been successfully added to your 
